Search is Powered by Google
Breast Cancer News

Study Finds No Breast Cancer Reduction From Calcium, Vitamin D Supplements

Main Category: Breast Cancer
Also Included In: Nutrition / Diet;  Clinical Trials / Drug Trials
Article Date: 14 Nov 2008 - 8:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:1 star

1 (2 votes)

Health Professional:2 stars

2 (2 votes)

Article Opinions: 0 posts

Women who took vitamin D and calcium supplements developed breast cancer at the same rate as those who did not take the supplements, according to a study by the Women's Health Initiative that is published in the Journal of the National Cancer Institute, the Boston Globe reports. According to the Globe, the findings "contradic[t] conclusions from previous studies that hinted at benefits from vitamin D." The authors -- led by Rowan Chlebowski of the University of California-Los Angeles -- wrote, "The main findings do not support a causal relationship between calcium and vitamin D supplement use and reduced breast cancer incidence, despite the association observed in some epidemiological studies," adding, "Current evidence does not support their use in any dose to reduce breast cancer risk" (Cooney, Boston Globe, 11/12).

For the study, the researchers tracked 36,282 postmenopausal women for an average of seven years. Each participant received a combined pill of 1,000 milligrams of calcium and 400 international units of vitamin D. Over the course of the study, 528 of the 18,176 women -- or 2.9% -- who received the combined pill developed invasive breast cancer, compared with 546 of the 18,106 women -- or 3% -- who received a placebo (Kaplan, Los Angeles Times, 11/12). According to the Globe, the difference between the groups is not considered statistically significant.

Jennifer Ligibel, a medical oncologist at the Dana-Farber Cancer Institute who was not involved in the study, said that the new research is the first rigorous test of vitamin D supplementation that accounts for factors that were not captured in earlier, observational studies. For example, she said that women who take dietary supplements might be healthier to begin with than those who do not, which could have influenced the previous studies. Ligibel added, "I think this is an important study. It tells us there is absolutely more work that needs to be done on vitamin D. I do think the study should put a little bit of brakes on people telling people to take huge doses of vitamin D to prevent cancer."

In an editorial also published in the journal, Corey Speers and Powel Brown of Baylor College of Medicine wrote that further research should be done to determine whether the age of the women, the dose of vitamin D they were taking, the calcium they took with it and hormone therapy might have confounded the results (Boston Globe, 11/12).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2008 The Advisory Board Company. All rights reserved.


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...